BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND SET, I2PP2A, 6418, ENSG00000119335, TAF-IBETA, PHAPII, IGAAD, 2PP2A
1604 results:

  • 1. Characterization of Alternative Splicing in High-Risk Wilms' tumors.
    Trink Y; Urbach A; Dekel B; Hohenstein P; Goldberger J; Kalisky T
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674106
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A three-gene expression score for predicting clinical benefit to anti-PD-1 blockade in advanced renal cell carcinoma.
    Betancor YZ; Ferreiro-Pantín M; Anido-Herranz U; Fuentes-Losada M; León-Mateos L; García-Acuña SM; Vaamonde-Rodríguez V; García-Pinel B; Cebey-López V; Villaverde-Viaño R; Lombardía-Rodríguez H; Kotrulev M; Fernández-Díaz N; Gomez-Tourino I; Fernández-Baltar C; García-González J; Tubio JMC; López-López R; Ruiz-Bañobre J
    Front Immunol; 2024; 15():1374728. PubMed ID: 38660294
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive bioinformatics analysis of KIF20A as a prognosis biomarker for clear cell renal cell carcinoma.
    Xie C; Yiu W; Mo Y
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):116-124. PubMed ID: 38650144
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Wide-Targeted Semi-Quantitative Analysis of Acidic Glycosphingolipids in Cell Lines and Urine to Develop Potential Screening Biomarkers for Renal Cell Carcinoma.
    Maekawa M; Sato T; Kanno C; Sakamoto I; Kawasaki Y; Ito A; Mano N
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612906
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. An Integrated Machine Learning Framework Identifies Prognostic Gene Pair Biomarkers Associated with Programmed Cell Death Modalities in Clear Cell Renal Cell Carcinoma.
    Chen B; Zhou M; Guo L; Huang H; Sun X; Peng Z; Wu D; Chen W
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):121. PubMed ID: 38538287
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pterostilbene suppresses gastric cancer proliferation and metastasis by inhibiting oncogenic JAK2/STAT3 signaling: In vitro and in vivo therapeutic intervention.
    He P; Li Y; Hu J; Deng B; Tan Z; Chen Y; Yu B; Dong W
    Phytomedicine; 2024 Jun; 128():155316. PubMed ID: 38518635
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep learning using contrast-enhanced ultrasound images to predict the nuclear grade of clear cell renal cell carcinoma.
    Bai Y; An ZC; Li F; Du LF; Xie TW; Zhang XP; Cai YY
    World J Urol; 2024 Mar; 42(1):184. PubMed ID: 38512539
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CRYL1 is a Potential Prognostic Biomarker of Clear Cell Renal Cell Carcinoma Correlated with Immune Infiltration and Cuproptosis.
    Li P; Xu Q; Liu K; Ye J
    Technol Cancer Res Treat; 2024; 23():15330338241237439. PubMed ID: 38497139
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Machine learning-driven prognostic analysis of cuproptosis and disulfidptosis-related lncRNAs in clear cell renal cell carcinoma: a step towards precision oncology.
    Chen R; Wu J; Che Y; Jiao Y; Sun H; Zhao Y; Chen P; Meng L; Zhao T
    Eur J Med Res; 2024 Mar; 29(1):176. PubMed ID: 38491523
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A nomogram based on TFE3 IHC results and clinical factors as a preliminary screening scheme for TFE3-rearranged renal cell carcinoma.
    Li P; Xu Q; Chen M; Zhu J; Wang Y; Mumin MA; Huang K; Jiang Z; Liang H; Deng Q; Wang Z; Liao B; Chen W; Cao Y; Cao J; Luo J
    Cancer Med; 2024 Mar; 13(5):e6813. PubMed ID: 38477529
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Health-related quality of life among adults living with chronic non-communicable diseases in the Ho Municipality of Ghana: a health facility-based cross-sectional study.
    Witts WK; Amu H; Dowou RK; Kwafo FO; Bain LE
    BMC Public Health; 2024 Mar; 24(1):725. PubMed ID: 38448856
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Using machine learning techniques to predict the risk of osteoporosis based on nationwide chronic disease data.
    Tu JB; Liao WJ; Liu WC; Gao XH
    Sci Rep; 2024 Mar; 14(1):5245. PubMed ID: 38438569
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Post Renal Transplant Malignancies; A Basic Concept.
    Nabi Z; Zahid T; Nabi R
    J Ayub Med Coll Abbottabad; 2023; 35(4):664-668. PubMed ID: 38406957
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Value of Dual-Energy Computed Tomography-Based Radiomics in the Evaluation of Interstitial Fibers of Clear Cell Renal Carcinoma.
    Bing X; Wang N; Li Y; Sun H; Yao J; Li R; Li Z; Ouyang A
    Technol Cancer Res Treat; 2024; 23():15330338241235554. PubMed ID: 38404055
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Fatty acid metabolism-related lncRNAs are potential biomarkers for survival prediction in clear cell renal cell carcinoma.
    Zhang MQ; Yang BZ; Wang ZQ; Guo S
    Medicine (Baltimore); 2024 Feb; 103(8):e37207. PubMed ID: 38394500
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognosis and biological function of SGOL1 in clear cell renal cell carcinoma: a multiomics analysis.
    Yang Z; Jiang Y; Wang L; Yu B; Cai H; Fan J; Zhang M
    BMC Med Genomics; 2024 Feb; 17(1):60. PubMed ID: 38383432
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Pan-cancer analysis predicts CANT1 as a potential prognostic, immunologic biomarker.
    Yang W; Liu Z; Liu T
    Cell Signal; 2024 May; 117():111107. PubMed ID: 38369265
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comprehensive analysis of m
    Li H; Li C; Zhang Y; Jiang W; Zhang F; Tang X; Sun G; Xu S; Dong X; Shou J; Yang Y; Chen M
    Mol Carcinog; 2024 Apr; 63(4):677-687. PubMed ID: 38362848
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Low expression of fatty acid oxidation related gene ACADM indicates poor prognosis of renal clear cell carcinoma and is related to tumor immune infiltration.
    Qiu J; Yang T; Sun Y; Sun K; Xu Y; Xia Q
    Oncol Res; 2024; 32(3):545-561. PubMed ID: 38361759
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Establishment of Twinning Partnership to Improve Pediatric Radiotherapy Outcomes Globally.
    Ali N; Amare E; Fekadu A; Awol M; Kayode O; Gebresenbet M; Nasir K; Dresser SA; Schriebmann E; Seife E; Esiashvili N
    JCO Glob Oncol; 2024 Feb; 10():e2300345. PubMed ID: 38359372
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 81.